Ascendis Pharma A/S (Ascendis Pharma A/S) Marketable Securities : $7.9 Mil (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Ascendis Pharma A/S Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Ascendis Pharma A/S's Marketable Securities for the quarter that ended in Dec. 2023 was $7.9 Mil.

Ascendis Pharma A/S's annual Marketable Securities increased from Dec. 2021 ($266.4 Mil) to Dec. 2022 ($307.9 Mil) but then declined from Dec. 2022 ($307.9 Mil) to Dec. 2023 ($7.9 Mil).

Ascendis Pharma A/S Marketable Securities Historical Data

The historical data trend for Ascendis Pharma A/S's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ascendis Pharma A/S Marketable Securities Chart

Ascendis Pharma A/S Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Marketable Securities

Get a 7-Day Free Trial

163.36

266.44

307.93

7.93

Ascendis Pharma A/S Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Marketable Securities	Get a 7-Day Free Trial															307.93	90.43	39.96	15.12	7.93

Ascendis Pharma A/S Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Ascendis Pharma A/S (NAS:ASND) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Ascendis Pharma A/S Marketable Securities Related Terms

Thank you for viewing the detailed overview of Ascendis Pharma A/S's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Ascendis Pharma A/S (Ascendis Pharma A/S) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ascendis Pharma A/S (NAS:ASND) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

ASND:Mexico A71:Germany A1SN34:Brazil

Address

Tuborg Boulevard 12, Hellerup, DNK, DK-2900

Website

http://www.ascendispharma.com

Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates in North America, China, and Europe and derives the majority of its revenue from North America.